ASCO 2019: Breast Cancer in the Hispanic Community

Published on

Topics include: Patient Stories

17% of the breast cancer community is Hispanic, but only 1% participate in clinical trials,” says patient advocate and two-time breast cancer survivor Barbara Segarra-Vazquez. How can clinical trial research better reflect the diverse patient population? On-site in Chicago at the 2019 American Society of Clinical Oncology (ASCO) meeting, Barbara discusses her advocacy work making the Hispanic voice heard and promoting inclusivity in research. Barbara also shares advice for self-advocacy and empowerment for those living with breast cancer.

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

View more programs featuring and

Related Programs

Breast Cancer Research Announced at ASCO 2018: Do All Patients Need Chemotherapy?

Can some breast cancer patients now forego chemo? What new findings are driving researchers toward shorter-term therapies? On location at ASCO 2018, expert Julie Gralow sheds light on the significant advances in breast cancer treatment.


The ABCs of Clinical Trials With Michele Nadeem-Baker, CLL Patient Advocate

Why should cancer patients consider a clinical trial, and what is the trial care like? Tune in as Phase II CLL clinical trial participant Michele Nadeem-Baker, discusses finding a good trial match and patient safety.


From Holistic Health Guru to Patient Advocate: The Importance of Respecting Evidence-Based Medicine

Myeloma patient and author Cherie Rineker shares how her perspective shifted from holistic care to becoming a myeloma treatment research advocate. Watch to learn why.


Join Our Community Register for Events Read Our Latest Blog

Page last updated on August 20, 2019